You are here

obesity

Weight-loss market to see 16 new drugs by 2029, report estimates

Reuters

Tue, 09/10/24 - 04:29 pm

Boehinger Ingelheim

Structure Therapeutics

Viking Therapeutics

Terns Pharmaceuticals' oral obesity drug shows promise in early study, shares jump

Reuters

Mon, 09/9/24 - 11:29 am

Terns Pharmaceuticals

clinical trials

OrsoBio Announces Oversubscribed $67 Million Series B Financing to Accelerate Mitochondrial Protonophore Portfolio Targeting Obesity and Associated Disorders

Businesswire

Fri, 09/6/24 - 10:50 am

57 Million Eligible For GLP-1 Drug Coverage In U.S. And That’s Just Those Under 65

Forbes

Thu, 09/5/24 - 10:29 pm

Amgen Plans Phase III Program for Next-Gen Obesity Drug Targeting Liver and Kidney Diseases

BioSpace

Thu, 09/5/24 - 11:40 am

BioAge files for IPO, plans pair of midstage obesity trials

Fierce Biotech

Wed, 09/4/24 - 11:40 am

clinical trials

Eli Lilly bets $1B in biobucks on Haya to scour dark genome for obesity targets

Fierce Biotech

Wed, 09/4/24 - 11:37 am

Haya Therapeutics

New research could ease concerns over suicide risk of obesity drugs

BioPharma Dive

Tue, 09/3/24 - 05:58 pm

Novo builds heart failure case for semaglutide

BioPharma Dive

Fri, 08/30/24 - 11:31 am

cardiovascular disease

Ambrosia lands $16m to ‘improve on existing GLP-1 drugs’

Longevity Technology

Wed, 08/21/24 - 11:26 am

Ambrosia Biosciences

Array Biopharma

Forget Mounjaro: Eli Lilly's Next Big Blockbuster Has Arrived

Motley Fool

Sun, 08/18/24 - 09:19 pm

After clearing out heart disease drug, Arrowhead maps out obesity development plans

Fierce Biotech

Wed, 08/14/24 - 10:41 pm

Arrowhead Pharmaceuticals

5 Obesity Readouts to Watch in the Second Half of 2024

BioSpace

Tue, 08/13/24 - 11:47 am

clinical trials

Terns Pharmaceuticals

Novo Nordisk pulls its FDA heart failure submission for Wegovy, will reapply early next year

Fierce Pharma

Wed, 08/7/24 - 11:47 am

Here's What AstraZeneca's CEO Has to Say About the Weight Loss Drugs Market

Motley Fool

Sun, 08/4/24 - 06:30 pm

Pfizer’s Bourla confident in company’s obesity drug position, despite delays

Pharma Voice

Thu, 08/1/24 - 11:14 am

GLP-1 drugs are driving up healthcare costs

Medical Marketing and Media

Fri, 07/26/24 - 11:03 am

healthcare costs

Roche says it’ll move quickly with ‘differentiated’ obesity drugs

BioPharma Dive

Thu, 07/25/24 - 10:05 pm

Carmot Therapeutics

Viking shares jump on plans to speed obesity drug into late-stage testing

BioPharma Dive

Thu, 07/25/24 - 11:23 am

Viking Therapeutics

clinical trials

Novo Nordisk's Wegovy gets UK approval for lowering heart risks

Reuters

Tue, 07/23/24 - 11:24 am

Pages